• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 79 of 100
House Oversight Hearing On Prescription Drug Price Increases
Health
Former Shkreli-Led Drug Developer Pledges Responsible Pricing
By ReutersApril 11, 2016
Apple Starts iPhone 6 Sales In Germany
Tech
A New Smartphone App Promises Help for Schizophrenia
By David Z. MorrisApril 9, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
Finance
Intercept Pharma’s Shares Spike Before Falling On Key FDA Panel Backing
By Sy MukherjeeApril 8, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health
Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By Sy MukherjeeApril 7, 2016
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Health
A Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer
By Sy MukherjeeApril 7, 2016
Losses mount for U.S. stocks.
Finance
This Pharma Company’s Stock Is Popping for No Clear Reason
By Sy MukherjeeApril 7, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
Cancer Treatment Costs Aren’t Rising as Fast as You Thought
By Laura LorenzettiApril 6, 2016
Over 400 Marijuana Stores Ordered To Close As City Regulates Industry
Retail
The DEA Will Soon Decide Whether it Will Reschedule Marijuana
By Tom Huddleston Jr.April 6, 2016
External Insulin Pump
Health
Lifesaving Diabetes Drug Price Tripled in 10 Years
By TIME and Alexandra SifferlinApril 6, 2016
Inside of a Gilead Sciences Lab
Health
The FDA Just Approved Another Next-Gen Gilead HIV Drug
By Sy MukherjeeApril 5, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
This Is Why Valeant’s Shares Are Soaring
By Lucinda ShenApril 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
Sex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force
By ReutersApril 5, 2016
DNA genetic testing (crop)
Health
GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
Makers Took Big Price Increases on Widely Used U.S. Drugs
Health
Makers Took Big Price Increases on Widely Used U.S. Drugs
By ReutersApril 4, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health
Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
1...
  • 77
  • 78
  • 79
  • 80
  • 81
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.